Delivery Order SPE2DB20D1109-SPE2DB25FP19Q
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,124.51 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a cardiovascular medication. The contract is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, and was awarded on November 25, 2025 with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,992.45 to supply 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in the treatment of heart failure. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $6,147.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with a completion date of December 2, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $7,495 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. This competitively awarded, firm fixed-price contract was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,128.12 delivery order on December 3, 2025, for 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in cardiac care. This is a firm fixed-price, non-set-aside contract with a completion date of December 4, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.12 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a cardiac medication used to treat heart failure. This firm fixed-price delivery order, issued December 5, 2025, represents a non-set-aside, competitively awarded contract with a completion deadline of December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $4,615.05 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count units) on August 5, 2025, with completion expected by August 6, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,304.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. The contract, which is a child order under a larger indefinite delivery vehicle, was competitively awarded without set-aside designation and is scheduled for completion by November 17, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,701.65 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count) with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,718.54 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. The award was made on September 22, 2025, under a firm fixed price contract type with an ultimate completion date of September 23, 2025. This non-set-aside delivery order was performed at the contractor's facility in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement within the...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP19QDelivery Order
The Defense Logistics Agency awarded a $7,357.10 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in heart failure treatment. This firm fixed-price delivery order, with an ultimate completion date of June 9, 2025, was awarded competitively without set-aside restrictions on June 6, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent receipt of competitive awards across multiple therapeutic domains demonstrates its established capability to meet federal medical procurement requirements for defense healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 6/6/25 |